Literature DB >> 1605307

Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.

J E Green1, A M Baird, S H Hinrichs, G K Klintworth, G Jay.   

Abstract

The expression of the human T-cell lymphotropic virus type 1 (HTLV-1) tax gene in transgenic mice has been shown to result in the development of neurofibromas. Further characterization of these transgenic mice has revealed other significant pathologic similarities between this transgenic mouse model and human neurofibromatosis (NF). Pheochromocytomas of the adrenal medulla and hamartomas of the iris are well-recognized manifestations of human NF. Adrenal medullary tumors have been found in 68% of transgenic animals that were studied. They appear, however, not to be pheochromocytomas, but rather composed of undifferentiated spindle cells. Proliferation of fibroblastlike cells in the iris also occurs in one-half of the transgenic animals surviving more than 6 months. Melanocytes, however, have not been found in the transgenic iris lesion, although they are characteristically found in the Lisch nodules of human NF. The similarities between human neurofibromatosis and this transgenic mouse model (in which the overexpression of a single gene results in neoplasia) are discussed. This transgenic system may provide further insights into molecular mechanisms involved in the pathogenesis of neurofibromatosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1605307      PMCID: PMC1886554     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.

Authors:  T Nakamura; M Hara; T Kasuga
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

2.  Pheochromocytoma and neurofibromatosis; report of a case.

Authors:  F H HEALEY; C J MEKELATOS
Journal:  N Engl J Med       Date:  1958-03-13       Impact factor: 91.245

3.  Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis.

Authors:  S Jacobson; C S Raine; E S Mingioli; D E McFarlin
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

4.  Eye findings in bilateral acoustic (central) neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules.

Authors:  M A Pearson-Webb; M I Kaiser-Kupfer; R Eldridge
Journal:  N Engl J Med       Date:  1986-12-11       Impact factor: 91.245

5.  c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.

Authors:  M Fujii; P Sassone-Corsi; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Letter: A new method for embedding with a low viscosity epoxy resin "Quetol 651".

Authors:  H Kushida
Journal:  J Electron Microsc (Tokyo)       Date:  1974

7.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

8.  trans activation of nerve growth factor in transgenic mice containing the human T-cell lymphotropic virus type I tax gene.

Authors:  J E Green
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Regulation of expression of human granulocyte/macrophage colony-stimulating factor.

Authors:  J Y Chan; D J Slamon; S D Nimer; D W Golde; J C Gasson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Absence of association of HTLV-I infection with type 1 neurofibromatosis in the United States or Japan.

Authors:  M I Nerenberg; T Minor; K Nagashima; K Takebayashi; K Akai; C A Wiley; V M Riccardi
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

View more
  7 in total

Review 1.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

2.  Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.

Authors:  L Feigenbaum; K Fujita; F S Collins; G Jay
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 3.  Neurofibromatosis and related tumors. Natural occurrence and animal models.

Authors:  V M Riccardi; J E Womack; T Jacks
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 4.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

Review 5.  Viral transformation and aneuploidy.

Authors:  Junichiro Yasunaga; Kuan-Teh Jeang
Journal:  Environ Mol Mutagen       Date:  2009-10       Impact factor: 3.216

6.  Characterization of Pheochromocytomas in a Mouse Strain with a Targeted Disruptive Mutation of the Neurofibromatosis Gene Nf1.

Authors:  Arthur S. Tischler; T. Shane Shih; Bart O. Williams; Tyler Jacks
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 7.  Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

Authors:  Daniel A Rauch; Lee Ratner
Journal:  Viruses       Date:  2011-06-21       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.